| 2024-05-28 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 300,000 0.5717% | $34.30 | $10.29M | -52.3% | |
| 2023-03-01 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 40,000 0.1006% | $24.21 | $968,231 | -4.21% | |
| 2023-02-02 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 11,250 0.0285% | $25.45 | $286,355 | -8.76% | |
| 2023-02-01 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 28,750 0.0707% | $24.73 | $710,856 | -8.69% | |
| 2023-01-04 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 7,105 0.0171% | $23.48 | $166,829 | -6.31% | |
| 2023-01-03 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 32,895 0.0837% | $23.77 | $781,770 | -2.01% | |
| 2022-12-06 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 40,000 0.0929% | $27.22 | $1.09M | -15.72% | |
| 2022-11-01 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 40,000 0.0929% | $33.51 | $1.34M | -29.48% | |
| 2021-03-24 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 17,000 0.0474% | $19.02 | $323,340 | +54.26% | |
| 2021-02-16 | Sale | Inhibrx, Inc. INBX | Chief Scientific Officer | 17,000 0.0496% | $25.90 | $440,300 | +18.81% |